Reference
NICE. Onasemnogene abeparvovec for treating spinal muscular atrophy Internet Document : 7 Jul 2021. Available from: URL: https://www.nice.org.uk/guidance/hst15
Rights and permissions
About this article
Cite this article
NICE recommends Zolgensma for type 1SMA in infants. PharmacoEcon Outcomes News 883, 34 (2021). https://doi.org/10.1007/s40274-021-7905-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7905-7